633 related articles for article (PubMed ID: 25290418)
1. Selection of patients for sublingual versus subcutaneous immunotherapy.
Larenas Linnemann DE; Blaiss MS
Immunotherapy; 2014; 6(7):871-84. PubMed ID: 25290418
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
Hesse L; Nawijn MC
Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
[TBL] [Abstract][Full Text] [Related]
3. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
4. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
Hesse L; Petersen AH; Nawijn MC
Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
[TBL] [Abstract][Full Text] [Related]
5. Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma.
Creticos PS; Gunaydin FE; Nolte H; Damask C; Durham SR
J Allergy Clin Immunol Pract; 2024 Jun; 12(6):1415-1427. PubMed ID: 38685477
[TBL] [Abstract][Full Text] [Related]
6. One-year evaluation of clinical and immunological efficacy and safety of sublingual versus subcutaneous allergen immunotherapy in allergic conjunctivitis.
Sayed KM; Kamel AG; Ali AH
Graefes Arch Clin Exp Ophthalmol; 2019 Sep; 257(9):1989-1996. PubMed ID: 31209565
[TBL] [Abstract][Full Text] [Related]
7. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
8. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective?
Nelson HS
J Allergy Clin Immunol Pract; 2014; 2(2):144-9; quiz 150-1. PubMed ID: 24607040
[TBL] [Abstract][Full Text] [Related]
10. Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms.
Yepes-Nuñez JJ; Guyatt GH; Gómez-Escobar LG; Pérez-Herrera LC; Chu AWL; Ceccaci R; Acosta-Madiedo AS; Wen A; Moreno-López S; MacDonald M; Barrios M; Chu X; Islam N; Gao Y; Wong MM; Couban R; Garcia E; Chapman E; Oykhman P; Chen L; Winders T; Asiniwasis RN; Boguniewicz M; De Benedetto A; Ellison K; Frazier WT; Greenhawt M; Huynh J; Kim E; LeBovidge J; Lind ML; Lio P; Martin SA; O'Brien M; Ong PY; Silverberg JI; Spergel J; Wang J; Wheeler KE; Schneider L; Chu DK
J Allergy Clin Immunol; 2023 Jan; 151(1):147-158. PubMed ID: 36191689
[TBL] [Abstract][Full Text] [Related]
11. Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost.
Dranitsaris G; Ellis AK
J Eval Clin Pract; 2014 Jun; 20(3):225-38. PubMed ID: 24444390
[TBL] [Abstract][Full Text] [Related]
12. SCIT Versus SLIT: Which One Do You Recommend, Doc?
Chaaban MR; Mansi A; Tripple JW; Wise SK
Am J Med Sci; 2019 May; 357(5):442-447. PubMed ID: 31010469
[TBL] [Abstract][Full Text] [Related]
13. Sublingual immunotherapy in children: the recent experiences.
Pleskovic N; Bartholow A; Skoner DP
Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):582-90. PubMed ID: 25188717
[TBL] [Abstract][Full Text] [Related]
14. Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis.
Wang ZX; Shi H
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):407-411. PubMed ID: 28585143
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy.
Pokladnikova J; Krcmova I; Vlcek J
Ann Allergy Asthma Immunol; 2008 May; 100(5):482-9. PubMed ID: 18517082
[TBL] [Abstract][Full Text] [Related]
16. Allergy immunotherapy: what is the evidence for cost saving?
Hankin CS; Cox L
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):363-70. PubMed ID: 24936851
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous Immunotherapy and Sublingual Immunotherapy: Comparative Efficacy, Current and Potential Indications, and Warnings--United States Versus Europe.
Nelson HS; Makatsori M; Calderon MA
Immunol Allergy Clin North Am; 2016 Feb; 36(1):13-24. PubMed ID: 26617224
[TBL] [Abstract][Full Text] [Related]
18. The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases.
Nolte H; Maloney J
Allergol Int; 2018 Jul; 67(3):301-308. PubMed ID: 29759659
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
Bahceciler NN; Cobanoglu N
Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of immunotherapy in allergic rhinitis.
Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C
Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 29025463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
